News

Beacon Therapeutics has completed the enrolment in its randomised, registrational Phase II/III VISTA trial of laru-zova ...
For the first time, thousands of live mosquitoes are being released in a Sacramento neighborhood to help prevent disease.
Topline data expected in H2 2026 LONDON and CAMBRIDGE, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Beacon Therapeutics Holdings Limited ("Beacon Therapeutics" or "the Company"), a leading clinical-stage ...
Icons, clichés, and overexposure: a brief history of our visual bulimia and how we ruined the images we once loved most.
A new book offers a portrait of an empire built on luxe fantasy, brought to life by big personalities and lavish spending ...
Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.
The male patient experienced fever, body aches, and a reddish skin rash, while the female patient had fever, swollen limbs, and joint pain ...
UAV Navigation–Grupo Oesía is supplying its flight control system for the DRIADE fixed-wing UAV developed by SE Aviation. The ...
The biotech will add a pivotal Phase III cohort to its ongoing Phase I/II trial evaluating ATSN-201 in X-linked retinoschisis ...
Researchers from the University of Florida Emerging Pathogens Institute and Texas A&M University recently gathered their ...